Biotech

Amgen teams up with Cambridge biotech community to select two start-ups to receive golden tickets at LabCentral

Amgen golden tickets provide innovative start-up companies with free lab space to aid in further advancement of their science

19 Dec 2017

Network Updates

Index Ventures closes €210M fund dedicated to early-stage European biotech

Index is splitting its life sciences and technology arms into two separate VC firms and launching Medicxi Ventures with new €210 million fund

03 Feb 2016

News

Italian biotech accelerator launched with €6M VC investment

New accelerator will initially work with the tech transfer team of three research institutes to uncover promising new ideas

18 Nov 2015

News

EU regulation proves its worth in driving innovation

It’s a virtuous circle: New approval processes put in place by the European Medicines Agency are de-risking drug development, promoting investment in early-stage biotech and meeting unmet medical needs, says Paul Morton

06 Feb 2013

Viewpoint

News

Norway’s Algeta to develop cancer therapies

Oslo-based anticancer company Algeta has closed a series A financing round totaling €23 million.

12 Oct 2005

News

New bio fund launched – and investment begins

A new life-science fund said it raised €240.3 million – and promptly announced its first two investments.

12 Oct 2005

News

Subscribe to Biotech

Biotech

Amgen teams up with Cambridge biotech community to select two start-ups to receive golden tickets at LabCentral

Index Ventures closes €210M fund dedicated to early-stage European biotech

Italian biotech accelerator launched with €6M VC investment

EU regulation proves its worth in driving innovation

Uppsala BIO opens BIO-X to projects in green and industrial biotechnology

Dutch researchers make advances in cancer detection with gold nanoparticles

Nautilus raises €8.4M for biosimilars

An end to France's biotech drought?

Norway’s Algeta to develop cancer therapies

New bio fund launched – and investment begins

Coronavirus R&D Gateway

The Network

Network Updates

Follow us on Twitter

Biotech

Coronavirus R&D Gateway

The Network

Most Read

Network Updates

Follow us on Twitter